Ketoprofen (KTP) is a chiral non-steroidal anti-inflammatory drug (NSAID) o
f the propionic acid class, approved by the FDA for the allevation of pain
associated with musculoskeletal disorders in horses. The present study was
designed to examine the bioavailability of ketoprofen enantiomers after rec
tal administration of the racemate to healthy horses. One gram of racemic k
etoprofen was injected intravenously and administered rectally as a fat bas
ed suppository in a cross-over design study (n = 4). Blood samples were ana
lysed for KTP enantiomers using HPLC. After IV administration, the S(+) ena
ntiomer concentrations in plasma were higher than the R(-) enantiomer conce
ntrations and the AUC(0-12 h) for the S(+) enantiomer was significantly hig
her than for the R(-) enantiomer. Following rectal administration C-max and
AUC(0-12 h) were significantly higher for the S(+) than for the R(-) enant
iomer. Bioavailability after rectal administration was low. Since there was
no significant difference in bioavailability between the two enantiomers,
it is assumed that no pre-systemic inversion from R(-) to S(+) occurred aft
er octal administration of racemic KTP to horses. (C) 1999 Harcourt Publish
ers Limited.